StockData
Medtronic plc logo

Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic diabetes Portfolio (Consolidated Segment) — Emerging Markets Revenue (Legacy through FY2024Q4, $M) ($M)

Legacy geographic split reported continuously from FY2016Q1 through FY2024Q4; replaced by unified International division tables starting FY2025Q1.

QuarterlyAnnual
Latest, Q4 FY24
99
Period ended Apr 30, 2024
Change on a year earlier
+20.7%
82 in Q4 FY23
History
38 quarters
Since Q3 FY15
Sources
34
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDiabetes Portfolio (Consolidated Segment) — Emerging Markets Revenue (Legacy through FY2024Q4, $M) ($M)Year on yearSource
Q4 FY24Apr 30, 202499+20.7%Medtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗
Q3 FY24Jan 31, 202494+17.5%Medtronic SEC 8K_EARNINGS — FY2024Q3 (filed 2024-02-20) ↗
Q2 FY24Oct 31, 202384+13.5%Medtronic SEC 8K_EARNINGS — FY2024Q2 (filed 2023-11-21) ↗
Q1 FY24Jul 31, 202375+4.2%Medtronic SEC 8K_EARNINGS — FY2024Q1 (filed 2023-08-22) ↗
Q4 FY23Apr 30, 202382+3.8%Medtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗
Q3 FY23Jan 31, 202380+17.6%Medtronic SEC 8K_EARNINGS — FY2024Q3 (filed 2024-02-20) ↗
Q2 FY23Oct 31, 202274+7.2%Medtronic SEC 8K_EARNINGS — FY2024Q2 (filed 2023-11-21) ↗
Q1 FY23Jul 31, 202272+14.3%Medtronic SEC 8K_EARNINGS — FY2024Q1 (filed 2023-08-22) ↗
Q4 FY22Apr 30, 202279+16.2%Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗
Q3 FY22Jan 31, 202268+23.6%Medtronic SEC 8K_EARNINGS — FY2023Q3 (filed 2023-02-21) ↗
Q2 FY22Oct 31, 202169+35.3%Medtronic SEC 8K_EARNINGS — FY2023Q2 (filed 2022-11-22) ↗
Q1 FY22Jul 31, 202163+31.3%Medtronic SEC 8K_EARNINGS — FY2023Q1 (filed 2022-08-23) ↗
Q4 FY21Apr 30, 202168+41.7%Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗
Q3 FY21Jan 31, 202155-12.7%Medtronic SEC 8K_EARNINGS — FY2022Q3 (filed 2022-02-22) ↗
Q2 FY21Oct 31, 202051-13.6%Medtronic SEC 8K_EARNINGS — FY2022Q2 (filed 2021-11-23) ↗
Q1 FY21Jul 31, 202048-12.7%Medtronic SEC 8K_EARNINGS — FY2022Q1 (filed 2021-08-24) ↗

Breakdown

What makes up diabetes portfolio (consolidated segment) — emerging markets revenue (legacy through fy2024q4, $m)

Cite this data

StockData. (2026). Medtronic Diabetes Portfolio (Consolidated Segment) — Emerging Markets Revenue (Legacy through FY2024Q4, $M) ($M), quarterly Q3 FY15–Q4 FY24 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/diab-seg-em-leg-rev

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.